PRD Therapeutics
PrivateLast Round
Grant
Jun 17, 2024
Total Funding Raised
$9.92M
Company Overview
PRD Therapeutics operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series A round in October 2023.
PRD Therapeutics is a biotechnology company that develops novel lipid metabolism regulators for rare diseases and lifestyle-related illnesses.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PRD Therapeutics Comparables
Compare PRD Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Regeneron Pharmaceuticals | 68% | |
| Repair Biotechnologies | 68% | |
| Chiesi Farmaceutici S.p.A. | 67% |
For institutional investors. Book with your work email.
PRD Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 17, 2024 | ||||
| Series A | Oct 6, 2023 | ||||
| Seed | Jun 8, 2022 | ||||
| Grant | Apr 1, 2022 |
For institutional investors. Book with your work email.
PRD Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| JAFCO Group Co., Ltd. | Series A |
| Japan Agency for Medical Research and Development | Grant |
| Mizuho Capital | Series A |
| JIC Venture Growth Investments | Series A |
| Taiho Innovations, LLC | Series A |
| Taiho Innovations, LLC | Seed |
| SMBC Venture Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 2, 2025
Monthly visitors increased 31% MoM, reaching 1K.
- Jun 17, 2024
Received grant funding from Japan Agency for Medical Research and Development.
For institutional investors. Book with your work email.
PRD Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PRD Therapeutics's valuation, stock price, and market status.
Is PRD Therapeutics a public or private company?
PRD Therapeutics is a private company.
What is the current stock price of PRD Therapeutics?
PRD Therapeutics is a private company, so its shares have no public market price. Caplight tracks PRD Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PRD Therapeutics worth (valuation)?
Valuation information for PRD Therapeutics is not publicly available.
Can I buy PRD Therapeutics stock?
PRD Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PRD Therapeutics's last funding round?
PRD Therapeutics's most recent funding round was Grant on June 17, 2024.
Who are the main investors in PRD Therapeutics?
Key investors in PRD Therapeutics include JAFCO Group Co., Ltd., Taiho Innovations, LLC.
Will PRD Therapeutics IPO soon?
No public IPO plans have been announced for PRD Therapeutics.
How can I track PRD Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in PRD Therapeutics's shares on secondary markets.